Talk:George Kollias (biologist)

Redirect
Articles about scientist George Kollias, sourced only to the subject's résumé and a company which employs him, have been deleted four times (deletion log) (deletion log) per the notability guideline and the what Wikipedia is not policy.

Wikipedia is an encyclopedia. It is not for advertising and it is not a web host. See also Wikipedia policy with regard to the re-creation of deleted material. — Athaenara ✉  10:30, 26 December 2007 (UTC)


 * Answer to user Athaenara:
 * Dr. George Kollias is a distinguished scientist with an H-index over 40. Dr. Kollias is not employed by a company but he is the President and Scientific Director of the non profit Biomedical Sciences Research Center "Al. Fleming". Wikipedia lists many other biologists, and academics and it is unfair to omit Dr. George Kollias


 * Please see the following:


 * http://en.wikipedia.org/wiki/Antonio_Lanzavecchia
 * http://en.wikipedia.org/wiki/Category:Italian_biologists
 * http://en.wikipedia.org/wiki/Category:Greek_academics —Preceding unsigned comment added by 77.49.145.45 (talk) 11:17, 26 December 2007 (UTC)

I agree with user with IP 77.49.145.45, George Kollias is a distinguished scientist and should be presented in wikipedia [user kanei22] —Preceding unsigned comment added by Kanei22 (talk • contribs) 13:58, 4 January 2008 (UTC)

Edit request from Kanei22, 14 January 2011
George Kollias, PhD, is President and Scientific Director of Alexander Fleming BSRC. He obtained his BSc and his PhD from the University of Athens, Greece. He was a postdoctoral fellow at the National Institute for Medical Research in London UK (1985–1987). He was the Head of the Laboratory of Molecular Genetics at the Hellenic Pasteur Institute in Athens, Greece, (1989–2000) and the Director of Institute for Immunology at FLM (2000–2002). Dr Kollias is an EMBO member. He has a long record in the generation and characterization of animal models of human diseases Kollias is a distinguished scientist with an H-index over 50. Dr. George Kollias, is a leading scientist in the field of TNF function in pathophysiology, highly reputed for establishing and characterizing disease pathways in animal models of chronic inflammation and autoimmunity (e.g. Rheumatoid Arthritis, Inflammatory Bowel Disease, Multiple Sclerosis, endotoxic shock and systemic lupus). His group was first to provide in vivo, proof of principle studies, on deregulated TNF production being causal to the development of chronic polyarthritis in a transgenic animal model, and for showing originally that anti-TNF antibody treatment was efficacious in treating the modelled disease. Dr. Kollias serves as an advisor for scientific organizations and consults for industry. He is also a reviewer for high-impact scientific Journals and evaluator for European Commission, National and International project and was recently elected and currently serves as President of the Council of the Directors of the Greek Research Centers (2009-2010).

Kanei22 (talk) 18:06, 14 January 2011 (UTC)

Edit request from Kanei22, 14 January 2011
George Kollias, PhD, is President and Scientific Director of Alexander Fleming BSRC. He obtained his BSc and his PhD from the University of Athens, Greece. He was a postdoctoral fellow at the National Institute for Medical Research in London UK (1985–1987). He was the Head of the Laboratory of Molecular Genetics at the Hellenic Pasteur Institute in Athens, Greece, (1989–2000) and the Director of Institute for Immunology at FLM (2000–2002). Dr Kollias is an EMBO member. He has a long record in the generation and characterization of animal models of human diseases Kollias is a distinguished scientist with an H-index over 50. Dr. George Kollias, is a leading scientist in the field of TNF function in pathophysiology, highly reputed for establishing and characterizing disease pathways in animal models of chronic inflammation and autoimmunity (e.g. Rheumatoid Arthritis, Inflammatory Bowel Disease, Multiple Sclerosis, endotoxic shock and systemic lupus). His group was first to provide in vivo, proof of principle studies, on deregulated TNF production being causal to the development of chronic polyarthritis in a transgenic animal model, and for showing originally that anti-TNF antibody treatment was efficacious in treating the modelled disease. Dr. Kollias serves as an advisor for scientific organizations and consults for industry. He is also a reviewer for high-impact scientific Journals and evaluator for European Commission, National and International project and was recently elected and currently serves as President of the Council of the Directors of the Greek Research Centers (2009-2010).

Kanei22 (talk) 18:06, 14 January 2011 (UTC)


 * Red information icon with gradient background.svg Not done: please provide reliable sources that support the change you want to be made. --Darkwind (talk) 03:41, 17 January 2011 (UTC)

External links modified
Hello fellow Wikipedians,

I have just modified one external link on George Kollias (biologist). Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:
 * Added archive https://web.archive.org/web/20110709012857/http://www.nimr.mrc.ac.uk/ to http://www.nimr.mrc.ac.uk/

When you have finished reviewing my changes, you may follow the instructions on the template below to fix any issues with the URLs.

Cheers.— InternetArchiveBot  (Report bug) 20:07, 13 October 2017 (UTC)